Listen to the SC Launch CEO Podcast, Featuring John Carrington of ZVerse
As businesses were closing due to the COVID-19 pandemic, ZVerse, an SC Launch, Inc. Portfolio Company, initially became concerned with possible staff layoffs, but instead, they made a bold step and shifted their operations to reusable face shields. They quickly responded to the needs of nurses and doctors while drastically expanding the size of its staff. ZVerse is now the largest reusable face shield supplier in the nation, and has since invented a non-clinical inverted shield. Listen to the podcast.
SCRA Portfolio Company Selected as GovTech 100 Company
Citibot, an SC Launch, Inc. Portfolio Company, was recently selected as a GovTech 100 company in 2021 by Government Technology News. The GovTech 100 is an annual list compiled and published by Government Technology as a compendium of 100 companies focused on, making a difference in, and selling to state and local government agencies across the United States. Read more.
Study Shows Typical Cancer-Free Survival Doubled for Recurrent Brain Cancer Patients when KIYATEC’s Test Informed Therapy Selection
KIYATEC, an SC Launch, Inc. Portfolio Company, announced the first clinical use of its response-prediction test to improve outcomes in relapsed brain cancer patients. Test results that measure the effect of cancer drugs on a patient’s live cancer cells are available in just seven days, thereby enabling oncologists to select drugs informed by patient-specific evidence of response before treatment begins.
Lindsay Lipinski, MD, Assistant Professor of Oncology and a neurosurgeon at Roswell Park Comprehensive Cancer Center (Buffalo, NY), presented her and her colleagues’ findings at the 2020 Society of Neuro-Oncology meeting in November. A case series of seven patients with recurrent high-grade gliomas – six with glioblastoma multiforme (GBM) and one with anaplastic astrocytoma – was detailed. Read more.
